Medication Safety of Elderly Patients in Hospital and Ambulatory Setting
NCT01578525 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 61
Last updated 2015-10-30
Summary
The purpose of this study is to determine whether additional pharmaceutical care for elderly patients (home-cared patients, nursing-home residents) has a positive impact on drug-related readmissions.
Conditions
- Elderly
- Pharmaceutical Care
- Hospital Readmission
- Health Services for the Aged
- Medication Safety
Interventions
- OTHER
-
Pharmaceutical Care Service
Checking medication under safety considerations (medication at admission, hospitalization, discharge); recommendations for potentially inappropriate medication (PRISCUS-criteria),
Sponsors & Collaborators
-
Apothekerstiftung Nordrhein, Duesseldorf
collaborator UNKNOWN -
Foerderinitiative Pharmazeutische Betreuung e.V., Berlin
collaborator UNKNOWN -
RWTH Aachen University
lead OTHER
Principal Investigators
-
Albrecht Eisert, Dr. rer. nat. · University Hospital Aachen, Hospital Pharmacy, Steinbergweg 20, 52074 Aachen, Germany
-
Axel Heidenreich, Prof. Dr. med. · University Hospital Aachen, Department of Urology, Pauwelsstr. 30, 50274 Aachen, Germany
-
Joerg B Schulz, Prof. Dr. med. · University Hospital Aachen, Department of Neurology, Pauwelsstr. 30, 52074 Aachen, Germany
-
Christian Trautwein, Prof. Dr. med. · University Hospital Aachen, Internal Medicine III (Gastroenterology and Metabolic Disorders), Pauwelsstr. 30, 52074 Aachen, Germany
-
Ulrich Jaehde, Prof. Dr. rer. nat. · University of Bonn, Pharmaceutical Institute, Clinical Pharmacy, An der Immenburg 4, 53121 Bonn, Germany
-
Rebekka Heumueller · University Hospital Aachen, Hospital Pharmacy, Steinbergweg 20, 52074 Aachen, Germany
-
Nicolaus Marx, Prof. Dr. med. · University Hospital Aachen,Internal Medicine I (Cardiology, Pneumology, Angiology and Internal Intensive Medicine)
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-04-30
- Primary Completion
- 2014-04-30
- Completion
- 2014-04-30
Countries
- Germany
Study Locations
More Related Trials
-
Medication Reconciliation Process in Clinical Practice
NCT07001137 ·Status: COMPLETED
-
An Intervention Study to Reduce Drug-related Problems and Readmissions Among Old People With Dementia
NCT01504672 ·Status: COMPLETED ·Phase: NA
-
Benefit of a Collaborative Approach to Improve the Quality of Medicines Use in Elderly Inpatients
NCT00279656 ·Status: COMPLETED ·Phase: PHASE4
-
Optimizing Drug-Therapy in Patients 80 Years and Older
NCT00661310 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Pharmaceutical Interventions in Hospitalized Patients
NCT04800900 ·Status: COMPLETED ·Phase: NA
-
Comprehensive Management of Drug Prescriptions Throughout the Elderly Person's Hospital Care
NCT03666793 ·Status: COMPLETED ·Phase: NA
-
Adverse Drug Reactions in Older Subjects
NCT03623542 ·Status: COMPLETED
-
Pharmaceutical Care in VA Nursing Home
NCT01823757 ·Status: UNKNOWN
-
Pharmaceutical Care of Patients With Impaired Mobility in a Model-region of Decreasing Supply of Medical Services
NCT01587599 ·Status: UNKNOWN ·Phase: PHASE4
-
OPTImization of Medication by Transdisciplinary Assessment of Drug Treatment in Elderly Hospitalized Patients
NCT05387096 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Pharmaceutical Care and Clinical Outcomes for the Elderly Taking Potentially Inappropriate Medication
NCT00844025 ·Status: UNKNOWN ·Phase: NA
-
Effect of a trAnSitional Pharmacist Intervention in geRiatric Inpatients on Hospitals Visits After dischargE
NCT04617340 ·Status: COMPLETED ·Phase: NA
-
Individual Risk Profiles for Adverse Drug Reactions in Geriatric Patients
NCT05247814 ·Status: NOT_YET_RECRUITING
-
Clinical Pharmacist Intervention to Reduce Drug-related Readmissions Among Older People
NCT03671629 ·Status: RECRUITING ·Phase: NA
-
Telephone Contact Between Hospital and General Practitioner About Medication Review for Older Patients
NCT03369652 ·Status: COMPLETED ·Phase: NA
-
Enhancing the Detection and Management of Adverse Drug Events in Nursing Homes
NCT01531088 ·Status: COMPLETED ·Phase: NA
-
Cooperation for Improved Pharmacotherapy in Home-dwelling Elderly People Receiving Polypharmacy - The COOP Study
NCT02379455 ·Status: COMPLETED ·Phase: NA
-
Medication Reviews Bridging Healthcare: a Cluster-randomised Crossover Trial
NCT02999412 ·Status: COMPLETED ·Phase: NA
-
Iatrogenic Drug Risk in People Over 75, With or Without Cognitive Disorders, From an Inventory of Their Family Pharmacy
NCT03686943 ·Status: WITHDRAWN
-
The Interprofessional Medication Assessment for Older Patients
NCT02398812 ·Status: UNKNOWN ·Phase: NA
-
Trial of a Pharmacist-physician Intervention Model to Reduce High-risk Drug Use by Hospitalised Elderly Patients
NCT02570945 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of Collaborative Pharmaceutical Care on Hospital Admission Drug Prescriptions for Patients 65 Years of Age and Older
NCT02598115 ·Status: COMPLETED ·Phase: NA
-
Impact of a Mobile Geriatric Team With a Pharmacist on the Optimisation of Prescriptions in Elderly Inpatients
NCT04151797 ·Status: COMPLETED ·Phase: NA
-
Effect of Systematic Medication Review in Elderly Patients Admitted to an Orthopedic Department
NCT00738816 ·Status: COMPLETED ·Phase: NA
-
A New Interdisciplinary Collaboration Structure to Improve Medication Safety in the Elderly
NCT02816086 ·Status: COMPLETED ·Phase: NA